Sciencast Management LP acquired a new position in shares of Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 12,545 shares of the company's stock, valued at approximately $330,000.
Several other large investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. grew its position in Celsius by 19.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,381,279 shares of the company's stock valued at $43,317,000 after purchasing an additional 221,833 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in Celsius by 85.4% in the fourth quarter. Janney Montgomery Scott LLC now owns 58,178 shares of the company's stock worth $1,532,000 after buying an additional 26,801 shares during the last quarter. iA Global Asset Management Inc. acquired a new stake in Celsius in the third quarter valued at approximately $2,772,000. Diversified Trust Co bought a new stake in Celsius in the fourth quarter worth approximately $869,000. Finally, Bennett Selby Investments LP increased its stake in shares of Celsius by 392.6% during the 4th quarter. Bennett Selby Investments LP now owns 51,645 shares of the company's stock worth $1,360,000 after purchasing an additional 41,161 shares during the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.
Celsius Stock Up 0.5 %
CELH traded up $0.18 during trading on Tuesday, hitting $35.06. The company's stock had a trading volume of 5,359,249 shares, compared to its average volume of 7,349,505. The firm's 50 day moving average price is $26.26 and its two-hundred day moving average price is $28.71. The stock has a market capitalization of $8.24 billion, a price-to-earnings ratio of 79.68, a price-to-earnings-growth ratio of 2.90 and a beta of 1.90. Celsius Holdings, Inc. has a 12 month low of $21.10 and a 12 month high of $98.85.
Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.11 by $0.03. The business had revenue of $332.20 million during the quarter, compared to analysts' expectations of $326.07 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. On average, sell-side analysts forecast that Celsius Holdings, Inc. will post 0.89 earnings per share for the current year.
Insider Activity
In other news, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the transaction, the director now owns 19,106 shares of the company's stock, valued at $543,947.82. This represents a 17.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Paul H. Storey sold 10,188 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the transaction, the insider now owns 45,297 shares in the company, valued at approximately $1,167,303.69. This represents a 18.36 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on CELH shares. TD Cowen cut shares of Celsius from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $40.00 to $29.00 in a report on Wednesday, January 22nd. JPMorgan Chase & Co. began coverage on Celsius in a research note on Thursday, December 12th. They set an "overweight" rating and a $37.00 price target for the company. Roth Mkm reissued a "buy" rating and set a $38.00 price objective on shares of Celsius in a report on Friday, February 21st. Needham & Company LLC boosted their price objective on shares of Celsius from $38.00 to $40.00 and gave the stock a "buy" rating in a research note on Tuesday, February 25th. Finally, Stifel Nicolaus decreased their target price on Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a research note on Monday, February 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Celsius has a consensus rating of "Moderate Buy" and a consensus price target of $45.00.
Check Out Our Latest Stock Report on Celsius
Celsius Profile
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.